The CD112R/CD112 axis: a breakthrough in cancer immunotherapy.
J Exp Clin Cancer Res. 2021 Sep 10;40(1):285. doi: 10.1186/s13046-021-02053-y.
J Exp Clin Cancer Res. 2021.
PMID: 34507594
Free PMC article.
Review.